WallStreetZenWallStreetZen

NYSE: BKD
Brookdale Senior Living Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for BKD

Based on 1 analyst offering 12 month price targets for Brookdale Senior Living Inc.
Min Forecast
$8.00+87.35%
Avg Forecast
$8.00+87.35%
Max Forecast
$8.00+87.35%

Should I buy or sell BKD stock?

Based on 1 analyst offering ratings for Brookdale Senior Living Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BKD stock forecasts and price targets.

BKD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 17%
17
Strong BuyMaintains$8.00+87.35%2022-07-25

1 of 1

Forecast return on equity

Is BKD forecast to generate an efficient return?
Company
-4.7%
Industry
-35.12%
Market
110.02%
BKD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BKD forecast to generate an efficient return on assets?
Company
-0.39%
Industry
7.36%
BKD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BKD earnings per share forecast

What is BKD's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.37
Avg 2 year Forecast
-$0.93
Avg 3 year Forecast
-$0.13

BKD revenue forecast

What is BKD's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$2.8B+6.72%
Avg 2 year Forecast
$3.0B+14.31%
Avg 3 year Forecast
$3.2B+21.05%
BKD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BKD revenue growth forecast

How is BKD forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
6.8%
Industry
6.72%
Market
8.53%
BKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BKD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BKD vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
BKD$4.27$8.00+87.35%Strong Buy
INNV$5.88$5.58-5.10%Hold
HNGR$18.72$18.75+0.16%Hold
HCSG$12.09$17.17+41.99%Hold
EHAB$14.04$18.00+28.21%Hold

Brookdale Senior Living Stock Forecast FAQ

Is Brookdale Senior Living Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: BKD) stock is to Strong Buy BKD stock.

Out of 1 analyst, 1 (100%) are recommending BKD as a Strong Buy, 0 (0%) are recommending BKD as a Buy, 0 (0%) are recommending BKD as a Hold, 0 (0%) are recommending BKD as a Sell, and 0 (0%) are recommending BKD as a Strong Sell.

If you're new to stock investing, here's how to buy Brookdale Senior Living stock.

What is BKD's earnings growth forecast for 2022-2024?

(NYSE: BKD) Brookdale Senior Living's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 2.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.13%.

Brookdale Senior Living's earnings in 2022 is -$91,851,000.On average, 3 Wall Street analysts forecast BKD's earnings for 2022 to be -$255,895,675, with the lowest BKD earnings forecast at -$259,631,378, and the highest BKD earnings forecast at -$252,159,971. On average, 3 Wall Street analysts forecast BKD's earnings for 2023 to be -$173,710,203, with the lowest BKD earnings forecast at -$227,877,900, and the highest BKD earnings forecast at -$95,260,434.

In 2024, BKD is forecast to generate -$24,282,071 in earnings, with the lowest earnings forecast at -$24,282,071 and the highest earnings forecast at -$24,282,071.

What is BKD's revenue growth forecast for 2022-2024?

(NYSE: BKD) Brookdale Senior Living's forecast annual revenue growth rate of 6.8% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Brookdale Senior Living's revenue in 2022 is $2,652,858,000.On average, 2 Wall Street analysts forecast BKD's revenue for 2022 to be $528,826,716,672, with the lowest BKD revenue forecast at $527,450,857,154, and the highest BKD revenue forecast at $530,202,762,975. On average, 2 Wall Street analysts forecast BKD's revenue for 2023 to be $566,410,880,232, with the lowest BKD revenue forecast at $558,287,780,235, and the highest BKD revenue forecast at $574,534,167,014.

In 2024, BKD is forecast to generate $599,836,272,115 in revenue, with the lowest revenue forecast at $599,836,272,115 and the highest revenue forecast at $599,836,272,115.

What is BKD's forecast return on assets (ROA) for 2022-2024?

(NYSE: BKD) forecast ROA is -0.39%, which is lower than the forecast US Medical Care Facilities industry average of 7.36%.

What is BKD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BKD price target, the average BKD price target is $8.00, with the highest BKD stock price forecast at $8.00 and the lowest BKD stock price forecast at $8.00.

The Wall Street analyst predicted that Brookdale Senior Living's share price could reach $8.00 by Jul 25, 2023. The average Brookdale Senior Living stock price prediction forecasts a potential upside of 87.35% from the current BKD share price of $4.27.

What is BKD's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: BKD) Brookdale Senior Living's current Earnings Per Share (EPS) is -$0.49. On average, analysts forecast that BKD's EPS will be -$1.37 for 2022, with the lowest EPS forecast at -$1.39, and the highest EPS forecast at -$1.35. On average, analysts forecast that BKD's EPS will be -$0.93 for 2023, with the lowest EPS forecast at -$1.22, and the highest EPS forecast at -$0.51. In 2024, BKD's EPS is forecast to hit -$0.13 (min: -$0.13, max: -$0.13).

What is BKD's forecast return on equity (ROE) for 2022-2024?

(NYSE: BKD) forecast ROE is -4.7%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.